Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kodiak Sciences Inc KOD

Healthcare Biotechnology
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti... see more

Recent & Breaking News (NDAQ:KOD)

Kodiak Sciences Announces Pricing of $560.9 Million Public Offering of Common Stock

PR Newswire November 17, 2020

Kodiak Sciences Announces Proposed Offering of Common Stock

PR Newswire November 16, 2020

Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration

PR Newswire November 16, 2020

Kodiak Sciences to Present at Upcoming Conferences

PR Newswire November 12, 2020

Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting

PR Newswire November 11, 2020

Kodiak Sciences Announces Third Quarter 2020 Financial Results and Recent Business Highlights

PR Newswire November 9, 2020

Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 - Two Studies in Diabetic Macular Edema and One Study in Macular Edema Due to Retinal Vein Occlusion

PR Newswire October 5, 2020

Kodiak Sciences to Present at Upcoming Conferences

PR Newswire September 2, 2020

Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent Business Highlights

PR Newswire August 10, 2020

Kodiak Sciences to Host R&D Webcast to Review Recent Data from the Ongoing Phase 1b Study of KSI-301 and Highlight KSI-301 Clinical Development Progress

PR Newswire July 16, 2020

Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting

PR Newswire July 10, 2020

Kodiak Sciences Announces Upcoming Presentation of KSI-301 Clinical Study Data at American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting and R&D Webinar

PR Newswire July 7, 2020

Kodiak Sciences to Present at Upcoming Conferences

PR Newswire May 28, 2020

Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference

PR Newswire May 11, 2020

Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights

PR Newswire May 11, 2020

Kodiak Sciences to Host First Quarter 2020 Business Highlights Webcast on May 12, 2020

PR Newswire May 8, 2020

Kodiak Sciences Appoints Charles Bancroft to Board of Directors

PR Newswire April 2, 2020

"Kodiak" and "Kodiak Sciences" Trademarks Registered to Kodiak Sciences Inc. for Its Exclusive Use

PR Newswire March 24, 2020

Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

PR Newswire March 16, 2020

Kodiak Sciences to Present at Upcoming Conferences

PR Newswire February 27, 2020